Prospective, Multicenter Evaluation of Transcarotid Artery Revascularization in Standard‐Risk Patients: 30‐Day Outcomes of the <scp>ROADSTER</scp> 3 Study
The 30-day results of the ROADSTER 3 study confirm that transcarotid artery revascularization is safe and effective in the standard-risk population. Longer-term follow-up is pending to confirm durable stroke prevention for these patients. ANN NEUROL 2026;99:705-712.
Authors
- Meghan Dermody (ORCID: https://orcid.org/0009-0007-1355-3076)
- Uttam Tripathy
- Scott S. Berman (ORCID: https://orcid.org/0000-0001-5236-7646)
- David O’Connor (ORCID: https://orcid.org/0000-0002-4679-0840)
- Rasesh Shah (ORCID: https://orcid.org/0000-0002-8727-3380)
- Daniel Calderón Gómez (ORCID: https://orcid.org/0000-0003-2116-2618)
- Angela Martin
- Jeffrey Jim (ORCID: https://orcid.org/0000-0001-6377-9590)
- Nicolas J. Mouawad (ORCID: https://orcid.org/0000-0002-8699-0572)
- Marc L. Schermerhorn (ORCID: https://orcid.org/0000-0002-2052-2573)
- Sumaira Macdonald (ORCID: https://orcid.org/0009-0001-7559-2210)
- Naveed Saqib
- Peter L. Faries
- Brian G. Peterson (ORCID: https://orcid.org/0000-0001-6871-2336)
- Joshua D. Adams (ORCID: https://orcid.org/0000-0003-1884-5549)
- Joseph J. Ricotta
Institutions
- Sentara Norfolk General Hospital (US)
- Houston Methodist (US)
- Memorial Hermann (US)
- Beth Israel Deaconess Medical Center (US)
- Mount Sinai Health System (US)
- Hackensack University Medical Center (US)
- University of Arizona (US)
- University of Evansville (US)
- McLaren Health Care (US)
- UPMC Central Pa (US)
- Lancaster General Hospital (US)
- Boston Scientific (United States) (US)
- St. Luke's Hospital (US)
- Deaconess Clinic (US)
- Delray Medical Center (US)
- Minneapolis Heart Institute Foundation (US)
- Houston Methodist Sugar Land Hospital (US)
- Hackensack Meridian Health (US)
- Center for Discovery (US)
- Deaconess Hospital (US)
- Carilion Clinic (US)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1002/ana.78104
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation